It is worth mentioning that, in the initial analysis, we conducted the same analysis in the TCGA-BRCA database for different subtypes of breast cancer and found no significant difference in survival when analyzing CAF infiltration and stromal score in triple-negative breast cancer and HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.